Additionally, recent studies suggest that ATGL activity in both tumours and neighbouring adipose tissue contributes to the adipocyte-induced metabolic reprogramming and aggressiveness of breast, pancreatic, and ovarian cancer [102,103,104,192]. This evidence concerns the gene PNPLA2 and neoplasm.